Therapeutic Drugs and Devices for Tackling Ocular Hypertension and Glaucoma, and Need for Neuroprotection and Cytoprotective Therapies
Damage to the optic nerve and the death of associated retinal ganglion cells (RGCs) by elevated intraocular pressure (IOP), also known as glaucoma, is responsible for visual impairment and blindness in millions of people worldwide. The ocular hypertension (OHT) and the deleterious mechanical forces...
Saved in:
Main Author: | Najam A. Sharif (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recently Approved Drugs for Lowering and Controlling Intraocular Pressure to Reduce Vision Loss in Ocular Hypertensive and Glaucoma Patients
by: Najam A. Sharif
Published: (2023) -
Topical Medication Therapy for Glaucoma and Ocular Hypertension
by: Tao Wang, et al.
Published: (2021) -
Neuroprotective therapies for glaucoma
by: Song W, et al.
Published: (2015) -
The Latest Drugs in Development That Reduce Intraocular Pressure in Ocular Hypertension and Glaucoma
by: Jayanetti V, et al.
Published: (2020) -
Ocular Drug Delivery for Glaucoma Management
by: Barbara Wirostko, et al.
Published: (2012)